MOH said it will provide an update when it is ready, with a decision expected to be made in 2026. Read more at straitstimes.com. Read more at straitstimes.com.

Lebrikizumab improved disease severity, skin clearance and symptom relief in children with moderate to severe atopic dermatitis, according to topline results from a phase 3 trial. “Dupilumab [Dupixent ...

Almirall, S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, today announced positive, top-line results from the pivotal Phase 3 ADorable-1 trial evaluating efficacy and ...

Eli Lilly scored $408 million in U.S. sales of eczema treatment Ebglyss in its first full year on the market in 2025. | With ...

ZORYVE cream 0.05% was safe and well-tolerated, with efficacy that was maintained and improved over time up to 56 weeks of treatmentChildren ages ...

Many over-the-counter supplements for dry skin include probiotics, omega-3 supplements, ceramides, hyaluronic acid, and other multivitamins.

U.S. drugmaker Pfizer said on Monday its experimental drug for a chronic skin ​disease met the main goal in a mid-stage ‌study.

Daily showering has been treated as non‑negotiable. But according to doctors, that routine may quietly work against us as we ...

Galderma has significantly raised its peak annual sales estimate for Nemluvio (nemolizumab) to more than $4 billion | Galderma has doubled its peak annual sales estimate for Nemluvio (nemolizumab) to ...

The campaign focuses on educating the one in 10 U.S. adults living with chronic hand eczema (CHE), particularly the one in three patients who have never heard the specific name of their condition.

The use of polluting household fuels and gas was associated with an increased likelihood of eczema, followed by severe asthma symptoms.